News
Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025
BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) ("Nordicus” or the "Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal condi
By: manilatimes
- Dec 18 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS